Valuation: R&G PharmaStudies Co., Ltd.

Capitalization 4.86B 664M 642M 606M 535M 951M 57.66B 1.06B 7.22B 2.68B 23.95B 2.49B 2.44B 101B P/E ratio 2024 *
33.9x
P/E ratio 2025 * 24.2x
Enterprise value 4.86B 664M 642M 606M 535M 951M 57.66B 1.06B 7.22B 2.68B 23.95B 2.49B 2.44B 101B EV / Sales 2024 *
6.15x
EV / Sales 2025 * 5.03x
Free-Float
30.26%
Yield 2024 *
0.4%
Yield 2025 * 0.46%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.58%
1 week+6.66%
Current month+6.66%
1 month+13.17%
3 months-27.94%
6 months+12.66%
Current year+0.56%
More quotes
1 week
47.36
Extreme 47.36
52.29
1 month
43.45
Extreme 43.45
52.29
Current year
43.45
Extreme 43.45
53.71
1 year
33.05
Extreme 33.05
73.08
3 years
33.05
Extreme 33.05
83.68
5 years
33.05
Extreme 33.05
83.68
10 years
33.05
Extreme 33.05
83.68
More quotes
Director TitleAgeSince
Investor Relations Contact 60 2008-08-21
Chief Executive Officer 64 2008-08-21
Director of Finance/CFO 41 2014-01-31
Manager TitleAgeSince
Chairman 64 2008-08-21
Director/Board Member 60 2008-08-21
Director/Board Member 53 2009-09-30
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-2.58%+6.66%+3.89% - 664M
-1.74%-2.32%+34.02%-0.70% 48.19B
-2.94%+0.42%-7.93%-17.76% 35.38B
+0.39%+1.30%+5.06%+23.81% 26.25B
-1.83%-3.06%-32.72%-28.37% 15.47B
+2.22%-0.03%+66.39%+73.56% 15.77B
-2.95%-9.48%-64.62%-80.83% 11.9B
-2.25%-5.80%+0.57%-34.69% 10.8B
-7.52%-5.51%+0.45%+87.46% 10.02B
+4.17%+15.13% - - 11.21B
Average -1.55%-0.56%+0.57%+2.81% 18.57B
Weighted average by Cap. -1.43%-0.47%+7.32%+1.29%
See all sector performances

Financials

2024 *2025 *
Net sales 790M 108M 104M 98.58M 86.97M 155M 9.38B 172M 1.17B 436M 3.9B 405M 397M 16.45B 966M 132M 128M 121M 106M 189M 11.47B 210M 1.44B 533M 4.77B 495M 486M 20.13B
Net income 165M 22.53M 21.78M 20.56M 18.14M 32.24M 1.96B 35.79M 245M 90.84M 812M 84.44M 82.78M 3.43B 200M 27.37M 26.45M 24.97M 22.03M 39.16M 2.38B 43.47M 297M 110M 987M 103M 101M 4.17B
Net Debt - -
More financial data * Estimated data
Logo R&G PharmaStudies Co., Ltd.
R&G PharmaStudies Co Ltd is a China-based company mainly engaged in the provision of professional clinical trial outsourcing services. The Company's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The Company operates its businesses primarily in the domestic market.
Employees
2,042
Calendar
More about the company
Date Price Change Volume
25-02-11 50.27 ¥ -2.58% 733,900
25-02-10 51.60 ¥ +3.45% 825,898
25-02-07 49.88 ¥ +0.87% 865,500
25-02-06 49.45 ¥ +2.28% 759,373

End-of-day quote Shenzhen S.E., February 10, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
50.27CNY
Average target price
59.50CNY
Spread / Average Target
+18.36%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301333 Stock